United States· US:71179-343_5b64261e-dad2-8a00-e063-6294a90afa93
Cold-EEZE Cold Remedy
A medicinal product containing zinc gluconate; glycyrrhiza glabra; sambucus nigra flower, registered in United States by Vespyr Brands LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ZINC GLUCONATE; GLYCYRRHIZA GLABRA; SAMBUCUS NIGRA FLOWER
- Manufacturer
- Vespyr Brands LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1171179-343-25
- ndc1171179-343-50
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/99f70d5f-3cd1-4e32-b863-0d1b5dedb0ff GET /v1/drugs/99f70d5f-3cd1-4e32-b863-0d1b5dedb0ff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "13.3; 4.5; 45",
"substance": "ZINC GLUCONATE; GLYCYRRHIZA GLABRA; SAMBUCUS NIGRA FLOWER",
"productndc": "71179-343",
"dosage_form": "LOZENGE",
"dea_schedule": null,
"strength_unit": "mg/1; mg/1; mg/1",
"application_number": null,
"marketing_category": "UNAPPROVED HOMEOPATHIC"
}See everything about zinc gluconate; glycyrrhiza glabra; sambucus nigra flower.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.